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Abstract
Purpose: Ameloblastomas are tumors that arise from the odontogenic epithelium, including 
the areas that coat the dentigerous cysts (DC). The aim of the present study was to investigate 
the proliferative activity present in luminal and mural areas of mural unicystic ameloblastomas 
(MUA), in conventional ameloblastomas (CA), and in DC, comparing them according to their 
biological behavior.
Methods: AgNOR quantifications were performed using routine light microscopy under X100 
magnification in 10 cases per type of lesion, considering 100 cells of representative areas of 
the tumor for each case. The AgNORs were observed as black dots within the cell nucleus.
Results: MUA showed significant lower number of NORs/nucleus in the luminal proliferation 
area than in the area of mural proliferation and in CA (P<0.05).
Conclusion:  CA  exhibit  proliferative  activity  similar  to  the  mural  component  of  MUA, 
corroborating the pattern of higher aggressive clinical behavior of these tumor variants.
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Resumo
Objetivo: Os ameloblastomas são tumores originados do epitélio odontogênico, inclusive 
daquele que reveste os cistos dentígeros (CD). O objetivo do presente trabalho foi avaliar 
a atividade proliferativa das áreas luminais e murais dos ameloblastomas unicísticos murais 
(AUM), ameloblastomas convencionais (AC) e cistos dentígeros (CD), comparando seus 
comportamentos biológicos. 
Metodologia: Para tanto foram selecionados 10 casos de AC, 10 casos de AUM e 10 
amostras de CD. A análise quantificativa das AgNORs foi realizada através de microscopia 
ótica de rotina com aumento de 100X nos 10 casos de cada lesão estudada, analisando-se 
100 células de áreas representativas do tumor. As AgNORs foram observadas como pontos 
pretos dentro do núcleo celular.
Resultados:  A  média  de  NORs/núcleo  da  área  de  proliferação  luminal  do  AUM  foi 
estatisticamente inferior à da área de proliferação mural desta mesma lesão e à do AC 
(P<0,05); nenhuma outra diferença estatística foi encontrada. 
Conclusão: Conclui-se que os AC exibem atividade proliferativa semelhante à do componente 
mural do AUM, o que corrobora o padrão de comportamento clínico mais agressivo dessas 
variantes clínicas.
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Introduction
Ameloblastoma is the most commom and clinically relevant 
odontogenic tumor. Its prevalence exceeds the prevalence of 
most tumors grouped, excluding the odontomas (1). Based 
mainly on clinical behavior and prognosis, there are two 
clinicopathological variants of intraosseous ameloblastoma: 
conventional ameloblastoma (CA), also known as solid or 
multicystic ameloblastoma, and unicystic ameloblastoma 
(UA) (2).
CA constitutes about 86 % of ameloblastomas, presenting 
several microscopic subtypes, but these different patterns 
relate poorly with the biological behavior of the tumor (1). 
The solid ameloblastoma is a locally aggressive tumor 
that  may  produce  marked  facial  deformity  and  serious 
debilitation. Since it tends to infiltrate the cancelous bone 
trabeculae, the real margin of the tumor extends itself beyond 
the radiographic margins. Even if the surgery is done with its 
marginal resection overcoming the radiographic borders of 
the tumor, it still yields recurrence rates up to 15% (1).
UA accounts for 13 % of all intraosseous ameloblastoma, 
and has a less aggressive clinical behavior, being frequently 
treated by enucleation or curettage. It can be originated from 
de novo or from neoplastic transformation of non-neoplastic 
cyst epithelium, especially from the dentigerous cyst (DC), 
which can be similar to UA in both clinical and radiographic 
aspects (1). There are three histopathological variants of 
UA: luminal, intraluminal, and mural ameloblastomas (3). 
The luminal unicystic ameloblastoma (LUA) presents a 
great cystic cavity lined partially or totally by ameloblastic 
epithelium, and a fibrous wall. The intraluminal unicystic 
ameloblastoma (IUA) is composed of anastomosing cords 
and of islands of epithelium, which are both projected into 
the cystic lumen. The mural unicystic ameloblastoma (MUA) 
presents islands of epithelium growing inside the connective 
tissue of the cyst wall. These islands are composed of 
peripheric collumnar epithelial cells and a centre that is 
identical to stellate reticulum (4). It is important to highlight 
that lesions with mural proliferation present a high risk   
of recurrence, justifying an extended follow-up in these 
cases (5).
The  determination  of  epithelial  proliferative  activity 
constitutes a useful way to investigate the differences among 
the biological behavior of tumors, defining the strategies 
of treatment, and their prognostic evaluation. Nucleolar 
organizer regions (NORs) are loops of DNA that codify the 
ribosomal RNA, and are considered important for protein 
synthesis (6). The transcriptional activity of the NORs is 
associated with non-histonic proteins, which are selectively 
marked by silver ions. The technique used to visualize the 
NORs is simple and can be performed in samples processed 
by routine methods. The NORs stained by silver are named 
argirophilic  nucleolar  organizer  regions  – AgNORs.  It 
has been consistently shown that AgNORs quantification 
represents  a  valuable  parameter  of  cell  kinectics  and, 
therefore, cell proliferation (7).
The literature has showed an arsenal of instruments used 
for different odontogenic tumors in the jaws, especially 
ameloblastomas (8-10) in order to evaluate the biological 
behavior of these lesions and establish the most appropriate 
treatment for their distinct pathological variants (11-13). 
However, there still are many doubts about the correlation 
between the clinical behavior and the proliferation activity 
of the ameloblastoma variants.
The specific goal of this study was to investigate the possible 
correlation  between  clinical  behavior  and  proliferation 
activity of two different variants of ameloblastoma: CA   
and MUA (luminal and mural areas), comparing them with   
the proliferation activity of DC, using the histochemical 
method  of  AgNORs  for  quantification  of  NORs  per 
nucleus. 
Methods
Case selection and morphological analysis
The present study was approved by the Research Ethics 
Committee of the Federal University of Pelotas – School 
of Dentistry. Ten cases of CA, 10 cases of MUA (all with 
mural and luminal proliferation areas), and 10 cases of DC 
were selected from the archives of the Department of Oral 
Pathology, School of Dentistry, Federal University of Pelotas. 
All cases had been fixed in 10 % formalin, routinely processed, 
and embedded in paraffin wax. Using haematoxylin and 
eosin-stained sections, the histopathological diagnosis of 
each case was reviewed, and the quality of the material was 
checked.
AgNORs histochemical technique
Three-µm sections were obtained, and the AgNOR technique 
was used according to Ploton et al. (14), modified by Rivero 
& Aguiar (15), with additional small modifications. To 
briefly describe the method, after the deparaffinization and 
rehydration processes, the slides were washed in running 
deionized water for 5 min. The slides were subjected to 
treatment with citric acid (Reagen, Rio de Janeiro, RJ, 
Brazil) 10 mM at pH 6.0, in a microwave oven at 700 W in 
three cycles of 5 min each, in order to optimize the silver 
staining. Afterwards  the  material  was  cooled  in  room 
temperature and then washed in running deionized water 
for 15 min. The excess of water was removed, and the slides 
were incubated in a freshly prepared solution made of one 
part of a solution composed of 2 g of gelatin (Labsynth, 
Diadema, SP, Brazil) and 1% aqueous formic acid solution 
mixed to two parts of 50% aqueous silver nitrate solution 
(Merck, Darmstadt, Germany). The slides were immersed in 
this solution for 25 min at 35ºC, washed in deionized water 
at 45ºC, and mounted in Permount (Fischer Scientific, Fair 
Lawn, USA).
Quantitative and statistical analysis
AgNORs  quantifications  were  performed  using  routine 
light  microscopy  and  AgNORs  were  evaluated  under 
X100 magnification and oil-immersion using an eye-piece 
graticule of 0.025 mm2. The AgNORs were observed as 12  Rev. odonto ciênc. 2009;24(1):10-14
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black dots within the cell nucleus. The number of separate 
black dots within the nucleus was recorded, and they were 
considered as one subject when the black dots were closely 
aggregated. When the examiner was in doubt, the area was 
not recorded for analysis. For calibration, two observers 
previously performed the counting procedure. 
For each type of lesion, the AgNORs of 100 cells were 
counted. These cells were taken from representative areas 
of the three odontogenic lesions. In the MUA cases, 100 cells 
from mural islands or nodules and 100 cells from luminal 
areas were assessed.
In the cystic epithelia of DC and in the luminal proliferation 
area of MUA, the graticule was positioned in order to count 
always the same proportion between the basal and parabasal 
cells. In the areas of mural proliferative islands of MUA and 
in the CA, the same proportion of peripheral and central 
cells was counted. Two calibrated examiners performed the 
AgNORs quantification, and the mean of NORs/nucleus of 
the two measurements was obtained.
The comparison among the means of NORs/nucleus among 
the three lesions, CA, CD and MUA (mural proliferation and 
luminal proliferation areas), was done by one-way analysis 
of variance (ANOVA) followed by Holm-Sidak test as   
post-hoc comparison test (α=0.05). 
Results
In all cases of CA, MUA and DC, AgNORs were visualized 
within the cellular nucleus as distinct and homogeneous dark 
dots with rounded morphology and regular boundary.
The mean number of NORs/nucleus of luminal proliferation 
areas for MUA (1.68±0.13) was significantly lower (P<0.05) 
than for the mural proliferation areas of MUA (2.02±0.22) 
and CA (2.06±0.22), whereas it was not statistically different 
from DC (1.83±0.32). Data are summarized in Table 1 and 
expressed as mean ± standard deviation values.
Table 1. Comparison among the mean number of NORs/
nucleus of CA, UA, and CD by ANOVA test.
Lesion NORs/nucleus (Mean±SD)
CA
Mural areas of MUA 
Luminal areas of MUA*
DC
2.06±0.22
2.02±0.22
1.68±0.13
1.83±0.32
* P<0.05 when compared to CA and mural area of MUA.
Discussion
Previous studies have related the cellular proliferation index 
with the biological behavior of ameloblastomas (8-10,16), 
and compared the proliferative activity of ameloblastomas 
with those of odontogenic cysts (8-13). Variations in AgNOR 
size and number might be dependent on the stage of the cell 
cycle, the transcriptional and metabolic cell activity or the 
number of NOR-bearing chromosomes in the karyotype (17). 
Audaciously, some authors have related the occurrence of 
smaller and more numerous AgNORs with the malignant 
potential of the lesions (18,19). According to these authors, 
AgNORs features can be used to assess the evolution of the 
degree of cellular proliferation as a prognostic measure for 
the tumor.
Fig. 1. (A) AgNOR staining in 
epithelium  of  the  dentigerous 
cyst; (B) mural proliferation areas 
of  unicystic  ameloblastoma;   
(C) luminal proliferation areas of 
unicystic ameloblastoma; (D) and 
conventional  ameloblastoma. 
The AgNORs are shown as black 
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The results of the present study showed a larger number 
of NOR per nucleus in CA than in luminal proliferation 
areas of MUA. These data could explain the less aggressive 
biological behavior of unicystic ameloblastomas presenting 
only luminal type of proliferation (LUA). On the other hand, 
it is in accordance with the clinically observed aggressive 
behavior of solid lesions of ameloblastomas (2,20). Moreover, 
these results combined with previous reports suggest a 
positive correlation between the number of AgNORs and 
the biological behavior of tumors (21). 
In  the  present  study  all  10  UA  cases  were  MUA,  and 
both luminal and mural areas were analyzed. When CA 
was compared to mural proliferation areas of MUA, no 
statistically significant difference was found. This result 
reinforces  the  already  known  aggressive  behavior  of   
MUA, which is similar to CA, considering recurrence ratio 
and prognosis (5,22,23). Besides, it seems that MUA is   
a lesion with higher proliferative capacity than LUA and 
IUA (24).
In contrast to the present results, Eslami et al. (10) did not 
find any statistically significant difference of AgNORs 
number per nucleus between UA and CA in odontogenic 
keratocysts. Some important methodological differences 
could explain such conflicting results as Eslami et al. (10) 
did not distinguish UA subtypes, grouping all MUA, LUA, 
and IUA areas in their AgNOR counting. Therefore, the 
higher proliferation activity of mural proliferation areas 
could have been masked by the low proliferation index of 
luminal and intraluminal sites, as these last ones would be 
more frequent.
In the present study, caution was taken to have proportional 
number of basal and parabasal cells in lesions of cystic 
features  (luminal  areas  of  MUA  and  DC)  for AgNOR 
counting. Also, the peripheral and central cells in epithelial 
odontogenic islands of mural areas of MUA and CA were 
counted in the same proportion. Eslami et al. (10) reported 
similar AgNOR counting only for OC, but this entity was 
not included in the present analysis. Curiously, although 
those authors have justified such counting procedure for 
OC based on the differences related to proliferation between 
the distinct zones of cystic epithelia (25), they did not use 
the same method to quantify AgNOR for other lesions. 
It is important to highlight that there is a lack of studies 
which used the AgNORs technique to analyze UA lesions 
distinguishing mural and luminal proliferation areas as 
adopted here. Coleman et al. (9) counted only the basal 
cells in unicystic ameloblastomas and in dentigerous cysts. 
Because they did not include other parabasal areas in their 
AgNOR counting, these tumors may have shown fewer 
AgNORs in these lesions than the real situation.
Finally,  when  the  DC  proliferation  index  values  were 
compared to the values observed in the studied variants 
of ameloblastoma, no statistically significant difference 
was found. The DC was included in this study especially 
because its epithelium lining can originate the ameloblastic 
epithelium (1). Although the DC can become a large lesion 
and expand the cortical bone of the jaws, the mechanism 
of  expansion  of  the  DC  is  considered  rather  passive, 
occurring by accumulation of fluid in the lumen instead 
of by the proliferation of its epithelium (13). A previous 
study showed different results when DC was compared with 
ameloblastomas, being the AgNOR counts of DC higher 
than AU (9). Coleman et al. (9) attributed these differences 
to the variations in metabolic, proliferation or transcriptional 
activity observed in these entities. However, Eslami et   
al. (10) described a lower number in DC when compared   
with  UA  and  CA.  Again,  the  lack  of  standardization 
of AgNOR  counting  may  have  interfered  in  their  data 
analysis. 
Other methods such as immunohistochemistry have been used 
to investigate cell proliferation antigens to compare cellular 
proliferation among CA, UA, and DC (11-13). Li et al. (24), 
based on the differences among the biological behavior of 
intraosseous ameloblastomas, compared the proliferative 
activity of these lesions by evaluating Proliferating Cell 
Nuclear Antigen (PCNA) and Ki-67. These authors showed 
that mural islands invading the fibrous capsule had higher 
number  of  these  antigens  than  intraluminal  nodes  and 
luminal epithelia in UA lesions. They also showed that CA 
exhibited higher PCNA and Ki-67 than all UA variants. 
Moreover, the precise localization of PCNA positive cells 
in CA and UA, defined by Piatelli et al. (11), was similar to 
the one found by Li et al. (24), i.e., peripheral cells of CA 
tumor islands and of the mural proliferation areas in MUA 
had similar PCNA indexes. These authors observed equal 
numbers of PCNA positive cells when they considered the 
basal cells of DC and of UA cystic epithelia. Besides, Sandra 
et al. (25) observed two distinct patterns of apoptosis in 
ameloblastomas: an anti-apoptotic proliferating site in the 
outer layer (periphery) of the islands and a pro-apoptotic 
differentiating site in the inner layer (centre). Although these 
proliferation markers are distinct from the one used in the 
present study (AgNORs), these findings somehow reinforce 
the method of AgNOR counting, proportionally evaluating 
peripheral and central cells of CA and MUA islands, and 
basal and parabasal cells of cystic epithelia of MUA luminal 
areas and DC epithelium lining.
Based on the results exposed, it can be concluded that 
the luminal proliferation areas of MUA exhibits lower 
proliferation activity than the mural proliferation areas. 
Besides, the same significant differences were observed 
when the luminal proliferation areas of MUA and CA were 
compared. Since the amount of AgNOR proteins is strictly 
proportional to the proliferative status of the cells, these 
results strongly reinforce the differences in the biological 
behavior  of  these  ameloblastoma  variants.  Moreover, 
AgNORs technique may be considered a good indicator of 
cell proliferation, but should not be regarded as a definitive 
or unique method.
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